Cargando…

Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort

BACKGROUND: Little is known about complications after major duodenopancreatic surgery for duodenopancreatic neuroendocrine tumors (dpNETs) in multiple endocrine neoplasia type 1 (MEN1). Therefore, the incidence and severity of complications after major surgery for MEN1-related dpNETs were assessed....

Descripción completa

Detalles Bibliográficos
Autores principales: van Beek, Dirk-Jan, Nell, Sjoerd, Vorselaars, Wessel M. C. M., Bonsing, Bert A., van Eijck, Casper H. J., van Goor, Harry, Nieveen van Dijkum, Elisabeth J., Dejong, Cornelis H. C., Valk, Gerlof D., Borel Rinkes, Inne H. M., Vriens, Menno R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253708/
https://www.ncbi.nlm.nih.gov/pubmed/33521900
http://dx.doi.org/10.1245/s10434-020-09496-1
_version_ 1783717571202121728
author van Beek, Dirk-Jan
Nell, Sjoerd
Vorselaars, Wessel M. C. M.
Bonsing, Bert A.
van Eijck, Casper H. J.
van Goor, Harry
Nieveen van Dijkum, Elisabeth J.
Dejong, Cornelis H. C.
Valk, Gerlof D.
Borel Rinkes, Inne H. M.
Vriens, Menno R.
author_facet van Beek, Dirk-Jan
Nell, Sjoerd
Vorselaars, Wessel M. C. M.
Bonsing, Bert A.
van Eijck, Casper H. J.
van Goor, Harry
Nieveen van Dijkum, Elisabeth J.
Dejong, Cornelis H. C.
Valk, Gerlof D.
Borel Rinkes, Inne H. M.
Vriens, Menno R.
author_sort van Beek, Dirk-Jan
collection PubMed
description BACKGROUND: Little is known about complications after major duodenopancreatic surgery for duodenopancreatic neuroendocrine tumors (dpNETs) in multiple endocrine neoplasia type 1 (MEN1). Therefore, the incidence and severity of complications after major surgery for MEN1-related dpNETs were assessed. METHODS: Patients were selected from the population-based Dutch MEN1 database if they had undergone a Whipple procedure or total pancreatectomy from 2003 to 2017. Complications were graded according to the Clavien–Dindo classification (grade III or higher complications were considered a severe complication) and definitions from the International Study Group of Pancreatic Surgery. The Cumulative Complication Index (CCI(®)) was calculated as the sum of all complications weighted for their severity. Univariable logistic regression was performed to assess potential associations between predictor candidates and a severe complication. RESULTS: Twenty-seven patients (median age 43 years) underwent a major duodenopancreatic resection, including 14 Whipple procedures and 13 total pancreatectomies. Morbidity and mortality were 100% (27/27) and 4% (1/27), respectively. A severe complication occurred in 17/27 (63%) patients. The median CCI(®) was 47.8 [range 8.7–100]. Grade B/C pancreatic fistulas, delayed gastric emptying, bile leakage, hemorrhage, and chyle leakage occurred in 7/14 (50%), 10/27 (37%), 1/27 (4%), 7/27 (26%), 3/27 (11%) patients, respectively. Patients with a severe complication had longer operative time and higher blood loss. After Whipple, new-onset endocrine and exocrine insufficiency occurred in 1/13 and 9/14 patients, respectively. CONCLUSIONS: Major duodenopancreatic surgery in MEN1 is associated with a very high risk of severe complications and cumulative burden of complications and should therefore be reserved for a select subgroup of patients with MEN1-related dpNETs. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09496-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8253708
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82537082021-07-20 Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort van Beek, Dirk-Jan Nell, Sjoerd Vorselaars, Wessel M. C. M. Bonsing, Bert A. van Eijck, Casper H. J. van Goor, Harry Nieveen van Dijkum, Elisabeth J. Dejong, Cornelis H. C. Valk, Gerlof D. Borel Rinkes, Inne H. M. Vriens, Menno R. Ann Surg Oncol Endocrine Tumors BACKGROUND: Little is known about complications after major duodenopancreatic surgery for duodenopancreatic neuroendocrine tumors (dpNETs) in multiple endocrine neoplasia type 1 (MEN1). Therefore, the incidence and severity of complications after major surgery for MEN1-related dpNETs were assessed. METHODS: Patients were selected from the population-based Dutch MEN1 database if they had undergone a Whipple procedure or total pancreatectomy from 2003 to 2017. Complications were graded according to the Clavien–Dindo classification (grade III or higher complications were considered a severe complication) and definitions from the International Study Group of Pancreatic Surgery. The Cumulative Complication Index (CCI(®)) was calculated as the sum of all complications weighted for their severity. Univariable logistic regression was performed to assess potential associations between predictor candidates and a severe complication. RESULTS: Twenty-seven patients (median age 43 years) underwent a major duodenopancreatic resection, including 14 Whipple procedures and 13 total pancreatectomies. Morbidity and mortality were 100% (27/27) and 4% (1/27), respectively. A severe complication occurred in 17/27 (63%) patients. The median CCI(®) was 47.8 [range 8.7–100]. Grade B/C pancreatic fistulas, delayed gastric emptying, bile leakage, hemorrhage, and chyle leakage occurred in 7/14 (50%), 10/27 (37%), 1/27 (4%), 7/27 (26%), 3/27 (11%) patients, respectively. Patients with a severe complication had longer operative time and higher blood loss. After Whipple, new-onset endocrine and exocrine insufficiency occurred in 1/13 and 9/14 patients, respectively. CONCLUSIONS: Major duodenopancreatic surgery in MEN1 is associated with a very high risk of severe complications and cumulative burden of complications and should therefore be reserved for a select subgroup of patients with MEN1-related dpNETs. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09496-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2021-01-31 2021 /pmc/articles/PMC8253708/ /pubmed/33521900 http://dx.doi.org/10.1245/s10434-020-09496-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Endocrine Tumors
van Beek, Dirk-Jan
Nell, Sjoerd
Vorselaars, Wessel M. C. M.
Bonsing, Bert A.
van Eijck, Casper H. J.
van Goor, Harry
Nieveen van Dijkum, Elisabeth J.
Dejong, Cornelis H. C.
Valk, Gerlof D.
Borel Rinkes, Inne H. M.
Vriens, Menno R.
Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title_full Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title_fullStr Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title_full_unstemmed Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title_short Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
title_sort complications after major surgery for duodenopancreatic neuroendocrine tumors in patients with men1: results from a nationwide cohort
topic Endocrine Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253708/
https://www.ncbi.nlm.nih.gov/pubmed/33521900
http://dx.doi.org/10.1245/s10434-020-09496-1
work_keys_str_mv AT vanbeekdirkjan complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT nellsjoerd complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT vorselaarswesselmcm complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT bonsingberta complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT vaneijckcasperhj complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT vangoorharry complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT nieveenvandijkumelisabethj complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT dejongcornelishc complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT valkgerlofd complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT borelrinkesinnehm complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort
AT vriensmennor complicationsaftermajorsurgeryforduodenopancreaticneuroendocrinetumorsinpatientswithmen1resultsfromanationwidecohort